Tag Archives: CVT

Hot China Stocks For 2019

China Mobile (NYSE:CHL) is generally considered a conservative play on the Chinese market. However, shares of the country’s top wireless carrier tumbled more than 30% over the past three years due to ongoing concerns about the saturation of the smartphone market, rising expenses, and trade tensions with the US.

But are investors overreacting to those headwinds? Let’s discuss the bear and bull cases to see if China Mobile is worth buying near its multi-year lows.

Image source: Getty Images.

What the bears think about China Mobile

China Mobile finished May with 901.9 million wireless subscribers, which represented 4.5% annual growth and 0.3% monthly growth. 671.8 million of those subscribers were on 4G plans, which represented 15.2% annual growth but just 0.4% monthly growth.

China Mobile’s 4G customer base shrank for the first time in April with a 0.4% month-over-month drop. That decline was caused by the saturation of China’s 4G market, as well as competition from smaller peers China Unicom (NYSE:CHU) and China Telecom (NYSE:CHA). The bears argue that this slowdown will persist until the three telcos transition to 5G networks.

Hot China Stocks For 2019: Oaktree Capital Group, LLC(OAK)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Asset management companies like Oaktree Capital Group (NYSE:OAK) have to deal with market volatility in two very different ways. On one hand, they have to produce the exceptional returns that keep them ahead of their peers even when conditions make it difficult. Yet even when they are able to outperform, asset managers also have to address the fears of their clients, many of whom start to flee in down markets even when their funds are holding up quite well.

  • [By Benzinga News Desk]

    President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

    ECONOMIC DATA
    USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90%
    The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET.
    The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.
    Data on farm prices for the recent week will be released at 3:00 p.m. ET.
    ANALYST RATINGS
    Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy
    Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight
    Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform
    KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

  • [By Leo Sun, Chuck Saletta, and Jordan Wathen]

    Rising interest rates can throttle demand for dividend stocks, but it’s foolish for investors to sell all of their dividend stocks on these cyclical dips. Today, three Motley Fool investors will discuss a trio of rock-solid stocks with yields exceeding 5%: AT&T (NYSE:T), Omega Healthcare Investors (NYSE:OHI), and Oaktree Capital Group (NYSE:OAK).

  • [By Ethan Ryder]

    The Manufacturers Life Insurance Company increased its holdings in shares of Oaktree Capital Group LLC (NYSE:OAK) by 101.1% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,600 shares of the asset manager’s stock after buying an additional 4,826 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Oaktree Capital Group were worth $380,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Chris Hill]

    In this Market Foolery podcast, host Chris Hill has a special guest — Foolish investor-at-large Tim Hanson — and they lead off with a discussion of the annual letter, released Wednesday, from billionaire investing guru Howard Marks of Oaktree Capital (NYSE:OAK). In it, Marks expressed concern about the number of questionable deals happening in this low-interest environment, as an excess of optimism and high risk-tolerance send capital toward assets it should probably shun at current prices. Then Chris and Tim respond to a podcast listener who’s wondering whether he should keep holding on to his General Motors shares. Beyond that, there’s a timely retrospective on Tim’s time at the Fool, and an equally timely debate on a divisive and controversial question: Are fun-size Halloween candies “fun” or a travesty?

  • [By Logan Wallace]

    Oaktree Capital Group LLC (NYSE:OAK) Director Larry W. Keele sold 8,333 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of $41.40, for a total transaction of $344,986.20. Following the completion of the transaction, the director now owns 8,656 shares in the company, valued at $358,358.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Hot China Stocks For 2019: Home BancShares, Inc.(HOMB)

Advisors’ Opinion:

  • [By Logan Wallace]

    BNP Paribas Arbitrage SA cut its stake in Home Bancshares Inc (NASDAQ:HOMB) by 61.5% during the first quarter, HoldingsChannel.com reports. The fund owned 51,186 shares of the financial services provider’s stock after selling 81,923 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Home Bancshares were worth $1,168,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Home Bancshares Inc (NASDAQ:HOMB) saw an uptick in trading volume on Friday . 3,045,400 shares were traded during trading, an increase of 269% from the previous session’s volume of 825,553 shares.The stock last traded at $22.76 and had previously closed at $22.71.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Home Bancshares (HOMB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Headlines about Home BancShares (NASDAQ:HOMB) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Home BancShares earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.7100995172055 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Money Morning News Team]

    The consolidation trend is setting up nicely for Home BancShares Inc. (NASDAQ: HOMB), a bank company that benefits from banking consolidation.

    HOMB invests in community banks, typically by purchasing and consolidating them.

  • [By Stephan Byrd]

    Bankwell Financial Group (NASDAQ: HOMB) and Home Bancshares (NASDAQ:HOMB) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

Hot China Stocks For 2019: CVENT, INC.(CVT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    CyberVein (CURRENCY:CVT) traded up 12.6% against the US dollar during the one day period ending at 18:00 PM ET on October 5th. CyberVein has a market capitalization of $20.74 million and $59,268.00 worth of CyberVein was traded on exchanges in the last 24 hours. One CyberVein token can now be purchased for about $0.0196 or 0.00000297 BTC on cryptocurrency exchanges including HitBTC, OKEx, IDEX and Bit-Z. Over the last seven days, CyberVein has traded down 12.5% against the US dollar.

  • [By Logan Wallace]

    CyberVein (CURRENCY:CVT) traded 7.6% lower against the US dollar during the one day period ending at 21:00 PM E.T. on June 9th. One CyberVein token can now be purchased for about $0.0625 or 0.00000853 BTC on major exchanges including Bit-Z, HitBTC and IDEX. CyberVein has a total market cap of $56.75 million and $10.82 million worth of CyberVein was traded on exchanges in the last 24 hours. During the last seven days, CyberVein has traded up 5.3% against the US dollar.

Top Tech Stocks To Invest In Right Now

We have argued in a previous article that the five titans of technology – Amazon (NASDAQ:AMZN), Google (GOOG, GOOGL), Facebook (NASDAQ:FB), Apple (NASDAQ:AAPL) and Microsoft (NASDAQ:MSFT) – are basically unstoppable.

In particular, Amazon, Google and Facebook are driven by multiple increasing return feedback loops, which makes their position virtually unassailable, we concluded. We also pointed out some downsides (here and here). These positions are getting on the nerves of some antitrust regulators, more specifically in the European Union.

Antitrust cases used to be simple. Companies had a dominant position, which led to a loss of consumer welfare and/or unfair competitive practices. Both of these were fairly easy to identify. A dominant position can be identified with the help of market share. A loss of consumer welfare or unfair competitive practices are a little harder to demonstrate with iron-clad proof, but usually these involve some price hikes or actions that limit competition or ties in buyers.

Top Tech Stocks To Invest In Right Now: Liquidity Services Inc.(LQDT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Press coverage about Liquidity Services (NASDAQ:LQDT) has been trending somewhat positive recently, according to Accern. The research group rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Liquidity Services earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 46.5172522637305 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Joseph Griffin]

    Eagle Boston Investment Management Inc. grew its stake in Liquidity Services, Inc. (NASDAQ:LQDT) by 4.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307,736 shares of the business services provider’s stock after purchasing an additional 12,917 shares during the quarter. Eagle Boston Investment Management Inc. owned approximately 0.96% of Liquidity Services worth $2,015,000 as of its most recent SEC filing.

  • [By Dan Caplinger]

    Most people who think about retail focus on the hot products that are always in demand. Yet at the other end of the spectrum are the products that perhaps were once needed but now find themselves either out of fashion or no longer necessary for the typical customer. That’s where Liquidity Services (NASDAQ:LQDT) comes in, offering a way for government and private sector clients to dispose of surplus inventory effectively and efficiently. That niche has challenges of its own, but the company has been making moves to build its business back up and hopefully return to profitability.

  • [By Stephan Byrd]

    Liquidity Services (NASDAQ:LQDT) last issued its quarterly earnings data on Thursday, May 3rd. The business services provider reported ($0.12) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.02. Liquidity Services had a negative net margin of 12.72% and a negative return on equity of 19.31%. The company had revenue of $43.10 million during the quarter, compared to the consensus estimate of $60.16 million. equities analysts forecast that Liquidity Services, Inc. will post -0.71 earnings per share for the current year.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top Tech Stocks To Invest In Right Now: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Internet Initiative Japan (IIJI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internet Initiative Japan (IIJI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Tech Stocks To Invest In Right Now: EMCORE Corporation(EMKR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    EMCORE Co. (NASDAQ:EMKR) traded up 8% during mid-day trading on Monday . The stock traded as high as $5.10 and last traded at $5.26. 11,341 shares changed hands during trading, a decline of 95% from the average session volume of 216,974 shares. The stock had previously closed at $4.87.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is the most shorted stock on the NASDAQ with short interest of 62.65% according to Highshortnterest.com.

  • [By Logan Wallace]

    News articles about EMCORE (NASDAQ:EMKR) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. EMCORE earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media coverage about the semiconductor company an impact score of 46.9972095148836 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Top Tech Stocks To Invest In Right Now: Applied Optoelectronics, Inc.(AAOI)

Advisors’ Opinion:

  • [By Anders Bylund]

    There is no doubt in my mind that high-speed network equipment and components will be in high demand for many years to come. That’s why I’m salivating over the rock-bottom prices that some of the best names in the industry are trading for right now. So let’s have a closer look at Finisar (NASDAQ:FNSR), Applied Optoelectronics Inc. (NASDAQ:AAOI), and NeoPhotonics (NYSE:NPTN), all of which have seen share prices sliding at least 20% lower over the last 52 weeks. These are great companies in a high-growth industry with legs that are good for miles and miles, and should be snapped up at these ridiculously low prices.

  • [By Anders Bylund]

    Fiber-optic networking specialist Applied Optoelectronics (NASDAQ:AAOI) slashed its third-quarter revenue guidance early Friday morning, sending its shares sharply lower. As of 10:35 a.m. EDT, Applied Optoelectronics traded 14.5% below Thursday’s closing price.

  • [By Anders Bylund]

    Shares of Applied Optoelectronics (NASDAQ:AAOI) are on the rise today thanks to a bullish analyst note. The maker of optical networking components and modules saw its stock price jump as much as 14% higher, backing down to a 13.1% gain as of 2:50 p.m. EDT.

  • [By Steve Symington]

    Shares of Applied Optoelectronics Inc. (NASDAQ:AAOI) were down 10.3% as of 3:15 p.m. EDT Thursday after an analyst downgraded shares of the fiber-optic networking products specialist.

  • [By Nicholas Rossolillo]

    Shares of fiber optic networking manufacturer Applied Optoelectronics (NASDAQ:AAOI) fell as much as 25% in late August through early September on tariff worries. Comments from the White House that taxes could be imposed on virtually all goods imported into the U.S. from China sent investors scurrying for the exits, and Wall Street analyst downgrades of some of AOI’s peers didn’t help either. Since the company has operations in China, it could be argued that the political concerns are valid. However, AOI is in good shape, and after another stock price adjustment, shares look like a value play again.

Top Tech Stocks To Invest In Right Now: CVENT, INC.(CVT)

Advisors’ Opinion:

  • [By Logan Wallace]

    CyberVein (CURRENCY:CVT) traded 7.6% lower against the US dollar during the one day period ending at 21:00 PM E.T. on June 9th. One CyberVein token can now be purchased for about $0.0625 or 0.00000853 BTC on major exchanges including Bit-Z, HitBTC and IDEX. CyberVein has a total market cap of $56.75 million and $10.82 million worth of CyberVein was traded on exchanges in the last 24 hours. During the last seven days, CyberVein has traded up 5.3% against the US dollar.

  • [By Stephan Byrd]

    CyberVein (CURRENCY:CVT) traded up 12.6% against the US dollar during the one day period ending at 18:00 PM ET on October 5th. CyberVein has a market capitalization of $20.74 million and $59,268.00 worth of CyberVein was traded on exchanges in the last 24 hours. One CyberVein token can now be purchased for about $0.0196 or 0.00000297 BTC on cryptocurrency exchanges including HitBTC, OKEx, IDEX and Bit-Z. Over the last seven days, CyberVein has traded down 12.5% against the US dollar.

Best Insurance Stocks To Invest In 2019

These 4 Emojis Are a No-No on Wall Street

Life Expectancy Holds Steady, but Not for 95-Year-Olds

5 Uses for Life Insurance That Most People Haven’t Thought Of

Americans set the Internet ablaze speaking out on Twitter. Yet speaking live to a crowd in public is still their No. 1 fear.

To get the word from an expert on how to prepare, present and benefit from making a speech, ThinkAdvisor interviewed Bernie Swain, co-founder and chair of Washington Speakers Bureau.

Any room for adlibbing within a prepared speech?

No, especially if you tend to ramble. You’ve got to stay on-theme. If you get into side stories, you lose the audience because you’ve taken them in a different direction.

But can’t practicing too much take freshness away from one’s presentation?

Great speakers practice like a musician practices their instrument. It’s mandatory to practice but in such a way that you’re able to criticize it and get others to do the same. Practice in front of family members and your staff.  Allow them to critique your performance. I used to practice in front of my wife [WSB co-founder Paula Swain]. She’d be hard on me: “Do it again – I’m not pleased with what you’re doing.” So you need to have someone that’s honest with you and will push you to keep practicing. Then you gain confidence, and it becomes easier.

Best Insurance Stocks To Invest In 2019: CVENT, INC.(CVT)

Advisors’ Opinion:

  • [By Logan Wallace]

    CyberVein (CURRENCY:CVT) traded 7.6% lower against the US dollar during the one day period ending at 21:00 PM E.T. on June 9th. One CyberVein token can now be purchased for about $0.0625 or 0.00000853 BTC on major exchanges including Bit-Z, HitBTC and IDEX. CyberVein has a total market cap of $56.75 million and $10.82 million worth of CyberVein was traded on exchanges in the last 24 hours. During the last seven days, CyberVein has traded up 5.3% against the US dollar.

Best Insurance Stocks To Invest In 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Best Insurance Stocks To Invest In 2019: CASI Pharmaceuticals, Inc.(CASI)

Advisors’ Opinion:

  • [By Logan Wallace]

    BidaskClub downgraded shares of CASI Pharmaceuticals (NASDAQ:CASI) from a strong-buy rating to a buy rating in a report released on Saturday morning.

  • [By Maxx Chatsko]

    Shares of CASI Pharmaceuticals (NASDAQ:CASI) jumped nearly 32% today after the small-cap pharma announced a new contract drug-manufacturing pact in China. The company now will rely on Yiling Wanzhou International Pharmaceuticals for manufacturing two drugs: entecavir and cilostazol.